Mann, Maretta, Thomson, Robin Joy, Dyason, Jeffrey Clifford, McAtamney, Sarah, Von Itzstein, Mark
Yes
Mann, Maretta, Thomson, Robin Joy, Dyason, Jeffrey Clifford, McAtamney, Sarah, Von Itzstein, Mark
Yes
Mann, Maretta, Thomson, Robin Joy, Dyason, Jeffrey Clifford, McAtamney, Sarah, Von Itzstein, Mark
The development of sialidase inhibitors is an area of continuing interest due to their potential use as therapeutic agents to combat viral and bacterial infections. Herein, we report our studies...
Haselhorst, Thomas Erwin, Wilson, Jenny, Thomson, Robin Joy, McAtamney, Sarah, Menting, John G., Coppel, Ross L., ...
Yes
Haselhorst, Thomas Erwin, Wilson, Jenny, Thomson, Robin Joy, McAtamney, Sarah, Menting, John G., Coppel, Ross L., ...
Yes
Haselhorst, Thomas Erwin, Wilson, Jenny, Thomson, Robin Joy, McAtamney, Sarah, Menting, John G., Coppel, Ross L., ...
Haselhorst, Thomas Erwin, Wilson, Jenny, Thomson, Robin Joy, McAtamney, Sarah, Menting, John G., Coppel, Ross L., ...
Saturation transfer difference (STD) 1H NMR experiments were used to probe the epitope binding characteristics of the sialidase [EC 3.2.1.18] from the bacterium Vibrio cholerae, the causative agent...